Part, Chapter, Paragraph
1 II, 5. 4. 4| than 30 times the dialysis/transplant incidence of Cyprus), so
2 II, 5. 4. 4| the prevalence of dialysis/transplant among countries is even
3 II, 5. 7. 1| treating patients living on a transplant are indeed by one-third
4 II, 5. 7. 1| 90~585.1~1-5 T if kidney transplant recipient~ ~2~Kidney damage~
5 II, 5. 7. 2| European Dialysis and Transplant Association (ERA-EDTA) that
6 II, 5. 7. 3| mortality risk reduction in transplant recipients was much higher:
7 II, 5. 7. 3| Although the better survival of transplant recipients is, at least
8 II, 5. 7. 5| improve organ donation and transplant activity. In 2002 new regulations
9 II, 5. 7. 5| prevention, dialysis and kidney transplant.~· The Austrian Ministry
10 II, 5. 7. 6| quality of life are higher in transplant recipients compared to dialysis
11 II, 5. 7. 7| to an end? Nephrol Dial Transplant 2007;22:678-80.~Jager KJ,
12 II, 5. 7. 7| strategies. Nephrol Dial Transplant 2001;16 Suppl 7:57-60~Lin
13 II, 5. 7. 7| assessments. Nephrol Dial Transplant 2006 Jul;21(7):1899-905.~
14 II, 5. 7. 7| 1990-1999. Nephrol Dial Transplant 2003 Sep;18(9):1824-33.~
15 II, 5. 7. 7| 1998-2002. Nephrol Dial Transplant 2006 Aug;21(8):2178-83.~
16 IV, 11. 5. 1| with a transplanted organ. Transplant procedures continue to develop
17 IV, 11. 5. 1| institutional centred, national transplant organizations (NTOs) based
18 IV, 11. 5. 1| different models, the EU transplant geography can be split into
19 IV, 11. 5. 1| exception of UKTSA (the UK Transplant Service Authority), virtually
20 IV, 11. 5. 1| the birth of international transplant exchange organizations in
21 IV, 11. 5. 2| Data sources~ ~A number of transplant organizations and scientific
22 IV, 11. 5. 2| operate in Europe~European transplant organizations on web:~ ~
23 IV, 11. 5. 2| ESOT) ( w ~ ~EU National transplant organizations on web:~-
24 IV, 11. 5. 2| and Croatia : ~ ~European transplant physician and organ procurement
25 IV, 11. 5. 2| on web:~- Collaborative Transplant Study (Heidelberg University ): h
26 IV, 11. 5. 2| Registry: htt European Liver Transplant Registry: htt International
27 IV, 11. 5. 2| International Islet Transplant Registry: htt Italian Dyalisis
28 IV, 11. 5. 2| Italian Dyalisis and Transplant Registry (RIDT): ht ISHLT
29 IV, 11. 5. 2| REDMO): ht Spanish Liver Transplant Registry: htt DOPKI: htt
30 IV, 11. 5. 2| DOPKI: htt ALLIANCE-O: htt Transplant Procurement Management: htt
31 IV, 11. 5. 3| assessment criteria in organ transplant~ ~Most of the risk assessment
32 IV, 11. 5. 3| Biological tests in organ transplant~ ~As Figure 11.16 shows,
33 IV, 11. 5. 4| in Europe waiting for a transplant. Mortality rates while waiting
34 IV, 11. 5. 4| for a heart, liver or lung transplant usually range from 15 to
35 IV, 11. 5. 4| the scarcity of organs for transplant is trafficking of human
36 IV, 11. 5. 4| was to become known as “transplant tourism” when prosperous
37 IV, 11. 5. 4| improved the functioning of transplant systems.~In order to expand
38 IV, 11. 5. 4| represents 17% of kidney transplant activity and 5% of liver
39 IV, 11. 5. 4| strong evidence of favourable transplant outcome and low donor risk.~
40 IV, 11. 5. 4| importance of having an efficient transplant system in place ensuring
41 IV, 11. 5. 4| establishment of adequate transplant systems at national level.
42 IV, 11. 5. 4| the local actors (hospital transplant teams and transplant coordinators)
43 IV, 11. 5. 4| hospital transplant teams and transplant coordinators) in the decision-making
44 IV, 11. 5. 4| Scandiatransplant, European Transplant Network or the regular meetings
45 IV, 11. 5. 4| into every stage of the transplant process in order to improve
46 IV, 11. 5. 4| risk-benefit analysis by the transplant team. Risks and characteristics
47 IV, 11. 5. 4| necessary documentation.~The transplant system must ensure traceability
48 IV, 11. 5. 4| consequences of not getting a transplant.~ ~
49 IV, 11. 5. 5| situation of the research in the transplant field at European level:~ ~
50 IV, 11. 5. 5| the actors involved in the transplant process: healthcare professionals,
51 IV, 11. 5. 5| An article published on Transplant International written by
52 IV, 11. 5. 5| European position in the transplant field; therefore, the European
53 IV, 11. 5. 5| issues in organ and cell transplant in order to join forces
54 IV, 11. 5. 5| cells (CSE) and solid organ transplant therapies,~2. new cell therapies
55 IV, 11. 5. 5| for CSE and solid organ transplant,~3. innovative training
56 IV, 11. 5. 5| whole staff involved in the transplant and research in the field
57 IV, 11. 5. 5| mobilisation of the European transplant community. To examine the
58 IV, 11. 5. 5| donation process, to grow to be Transplant Coordinators and lead organ
59 IV, 11. 5. 5| a European donation and transplant activity registry for delivering
60 IV, 11. 5. 6| responsible for organ donation (transplant “donor co-ordinators”)~2004Guide 4)~
61 IV, 11. 5. 6| the management of organ transplant waiting lists and waiting
62 IV, 11. 5. 6| experience acquired by the transplant surgical and medical teams.~ ~
63 IV, 11. 5. 7| addressing a strengthened transplant cooperation among Member
64 IV, 11. 6. 5| towards novel opportunities? Transplant International 2007, distributed
65 Key, Ap5. 0. 0| trafficking~transfusion~transplant~transplantation~transplanted~
